Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health Inc
(NQ:
GH
)
20.63
+2.67 (+14.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,569,157
Open
18.20
Bid (Size)
20.50 (1)
Ask (Size)
20.81 (2)
Prev. Close
17.96
Today's Range
18.13 - 20.75
52wk Range
16.91 - 41.06
Shares Outstanding
101,298,669
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...
Via
Benzinga
Insiders Buying Advance Auto Parts And 2 Other Stocks
March 20, 2024
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Performance
YTD
-22.18%
-22.18%
1 Month
+5.63%
+5.63%
3 Month
-25.95%
-25.95%
6 Month
-31.37%
-31.37%
1 Year
-12.55%
-12.55%
More News
Read More
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
March 13, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2024
From
Guardant Health, Inc.
Via
Business Wire
4 Analysts Have This To Say About Guardant Health
February 23, 2024
Via
Benzinga
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
March 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test
February 23, 2024
Via
Benzinga
Exposures
Product Safety
Guardant Health: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
February 15, 2024
From
Guardant Health, Inc.
Via
Business Wire
Decoding 4 Analyst Evaluations For Guardant Health
January 30, 2024
Via
Benzinga
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
February 01, 2024
From
Guardant Health, Inc.
Via
Business Wire
3 Stocks to Buy for the Age of Personalized Medicine
January 28, 2024
Via
InvestorPlace
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
January 17, 2024
From
Guardant Health, Inc.
Via
Business Wire
Bull of the Day - NeoGenomics
January 12, 2024
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
January 08, 2024
Via
InvestorPlace
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results
January 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024
January 08, 2024
Via
The Motley Fool
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
January 08, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
January 02, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford
December 21, 2023
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 20, 2023
From
Guardant Health, Inc.
Via
Business Wire
Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise Advisory Possibility: Analyst
December 20, 2023
Via
Benzinga
Exposures
Product Safety
S&P 500, Nasdaq Set For Weaker Open As 'FOMO' Rally Cools: Analyst Says Only 'Black Swan Could Upset Santa's Sleigh' Now
December 20, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 19, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.